Next 10 |
home / stock / albby / albby news
2023-06-03 03:36:00 ET Summary Alibaba Health reported a surge in revenues and a record profit of 534 million yuan ($75.2 million) due to the growth of online healthcare in China. The company's core money-earner is direct drug sales, which generated 23.59 billion yuan in revenue i...
LinkDoc has formally withdrawn its plan to raise $200 million from a U.S. IPO, nine months after its 11th hour halt to the listing. Three other Chinese companies with pending U.S. listings could revive their plans in the second half of this year as last year’s regulatory turmoi...
In a repeat of the previous week, we have positive coverage again from the likes of Financial Times and The WSJ but the representative ETFs of Chinese companies ended in the red. The regulatory crackdown on the internet industry has shifted to the healthcare sector, promptin...
Another week, another sector came under the scrutiny of the Chinese government, helping to divert market players from the internet stocks. There are silver linings from the Macau casino regulatory scrutiny that could benefit the Chinese internet sector. Baidu announced several pos...
There was a plethora of bad news in the past week. I offer my take as to why market players brushed each one of them off. The Chinese President made further declarations related to the Chinese internet sector but I explain why it's music to the ears of investors clamoring for mor...
It was an excruciating week of a severe emotional storm with the share prices undergoing a rollercoaster ride. A deluge of news, speculations, and commentaries overwhelmed the mind. The massive and synchronized sell-off of Chinese equities was akin to a Golden Slam for the critics. It...
Investors continued to take profit off stocks that had seen a good run-up year-to-date and redeployed some proceeds into energy and materials names as well as reopening trades. Chinese equities were particularly hard-hit amidst the fanning of the flames of U.S.-China political te...
An executive order by the U.S. President led to indices providers taking pre-emptive actions and we saw heavy selling pressure on certain Chinese stocks ahead of complications. JD Health surged on its public debut but shareholders of JD.com weren't pleased. I argue this is a buying op...
The release of the bullish Chinese industrial profitability fired up animal spirits among investors. Vipshop continued to bask in its post-Q3 results glamor, however, the pending anti-monopoly policy targeting platform operators could negatively affect Vipshop. iQIYI plunged as sh...
By ALT Perspective The buoyant U.S. stock markets early in the week belied the volatility in Asia caused by what Peter Navarro said in an interview where he had to subsequently clarify a particular comment was taken "wildly out of context." The White House trade adviser and longtime Ch...